D-0798-2021 Class III Terminated

Recalled by Viatris — Morgantown, WV

FDA drug recall D-0798-2021 was initiated by Viatris on Sep 13, 2021 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; out of specification for Related Compound The recall status is terminated (terminated Apr 28, 2022). Affected quantity: 21,094.

Recall details

Product Type
Drugs
Report Date
Sep 22, 2021
Initiation Date
Sep 13, 2021
Termination Date
Apr 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
21,094

Product description

Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93

Reason for recall

Failed Impurities/Degradation Specifications; out of specification for Related Compound

Distribution pattern

Product was distributed nationwide.

Code information

Lot # 3107334, exp. date October 2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0798-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0798-2021. Report a data issue: hello@regdatalab.com.